A Novel Insight into Postmenopausal Hypercholesterolemia: Carnitine as a Key Player

Area of Science:

• Metabolomics
• Cardiovascular Disease Research
• Menopause Studies

Background:

• Postmenopausal women face increased cardiovascular disease risk, particularly hypercholesterolemia.
• Understanding metabolic changes is key to identifying biomarkers and therapeutic targets for this condition.

Purpose of the Study:

• To investigate metabolomic variations in postmenopausal women to find markers and targets for hypercholesterolemia.
• To explore the role of carnitine in postmenopausal hypercholesterolemia using mouse models and in vitro studies.

Main Methods:

• Metabolomic analysis using Ultra-Performance Liquid Chromatography Quadrupole Orbitrap Mass Spectrometry (UPLC-Q-Orbitrap MS).
• Ovariectomized mouse models and HepG2 cell cultures were used to assess carnitine's effects.
• Hematoxylin and eosin staining and Western blot analysis were employed to evaluate arterial integrity and enzyme levels.

Main Results:

• Carnitine treatment in postmenopausal mice increased plasma cholesterol, carnitine levels, and arterial sclerosis indicators.
• In HepG2 cells, carnitine elevated lipid levels, reactive oxygen species (ROS), and decreased antioxidant enzymes.

Conclusions:

• Carnitine may act as a risk marker or therapeutic target for postmenopausal hypercholesterolemia.
• The study offers insights into cardiovascular conditions in postmenopausal women and potential therapeutic avenues.